Breast Cancer Screening with Digital Breast Tomosynthesis: Are Initial Benefits Sustained?
2020 · Radiology · 40 citations
https://doi.org/10.1148/radiol.2020191030
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.4K
Citations
18
h-index
28
i10-index
Sarah Mercaldo is an academic researcher from Harvard University. The author has contributed to research in topics: Global Cancer Incidence and Screening & AI in cancer detection & Digital Radiography and Breast Imaging. The author has an h-index of 18, co-authored 63 publications.
ORCID: 0000-0001-8519-1982https://doi.org/10.1148/radiol.2020191030
https://doi.org/10.2214/ajr.18.20566
https://doi.org/10.1093/jbi/wbz024
https://doi.org/10.1038/s41598-025-23183-9
Click to start Chat